VMC
62
-3
M
31
-5
SO
55
-2
NWS
79
-4
MSI
79
-2
EXPD
40
-3
XRAY
17
-12
NUE
62
-2
UA
51
-6
STI
12
-5
KMB
28
-2
DE
40
4
A
40
-3
AMT
34
-2
IRM
42
-4
AZO
58
5
HP
44
3
TEL
68
-3
AFL
49
3
WDC
46
-4
VMC
62
-3
M
31
-5
SO
55
-2
NWS
79
-4
MSI
79
-2
EXPD
40
-3
XRAY
17
-12
NUE
62
-2
UA
51
-6
STI
12
-5
KMB
28
-2
DE
40
4
A
40
-3
AMT
34
-2
IRM
42
-4
AZO
58
5
HP
44
3
TEL
68
-3
AFL
49
3
WDC
46
-4
Financhill
Back

Verrica Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
25

VRCA
Verrica Pharmaceuticals

Last Price:
0.92
Seasonality Move:
34.27%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
66.13
Seasonality Move:
13.04%
Sell
25
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $0.96. The Score for VRCA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.36. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $0.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 37.03 Sell
Chaikin Money Flow: 922828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.05 - 1.63) Sell
Bollinger Bands (100): (1.13 - 6.41) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.73 Sell
Relative Strength Index (14 RSI): 34.15 Sell
Chaikin Money Flow: -864914 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.92 - 70.46) Sell
Bollinger Bands (100): (70.6 - 88.08) Sell

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.05 Sell
20-day SMA: 1.34 Sell
50-day SMA: 1.57 Sell
200-day SMA: 5.22 Sell
8-day EMA: 1.02 Sell
20-day EMA: 1.26 Sell
50-day EMA: 1.94 Sell
200-day EMA: 4.27 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.38 Sell
20-day SMA: 68.48 Sell
50-day SMA: 72.64 Sell
200-day SMA: 82.19 Sell
8-day EMA: 66.88 Sell
20-day EMA: 68.21 Sell
50-day EMA: 72.28 Sell
200-day EMA: 80.84 Sell

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.73 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):